Showing results (171-180 of 961) with videos related to

Sort By:
Pageof 97
Ejhaem|August 19, 2024
Overcoming post-transplant graft failure and adenovirus infection in a patient with FLT3-TKD-mutated mixed-phenotype acute leukemia: A case reportYusuke Takada, Shuhei Kurosawa, Toshimitsu Ueki, et al.
Ejhaem|August 19, 2024
Use of IV immunoglobulin to treat steroid resistant, immune checkpoint inhibitor-induced pure red cell aplasia: A case reportSam Sherratt-Mayhew, Phillip L R Nicolson
Ejhaem|August 19, 2024
Iatrogenic hemorrhage and extensive venous thromboembolism during iTTP treatment with caplacizumab-A case reportErik Boberg, Adrian Kimiaei, Cecilia Karlström, et al.
Ejhaem|June 19, 2024
B-cell maturation antigen-based therapies post-talquetamab in relapsed or refractory multiple myelomaAsis Shrestha, Marah Alzubi, Jawad Alrawabdeh, et al.
Ejhaem|June 19, 2024
Development of the treatment preference in myelodysplasia questionnaire for clinicians, carers, and patientsRobert Morlock, Chun Fong, Francesco Castaldi, et al.
Ejhaem|June 19, 2024
PICALM::MLLT10 may indicate a new subgroup of acute leukemias with miscellaneous immunophenotype and poor initial treatment response but showing sensitivity to venetoclaxHaimin Sun, Yongmei Zhu, Jianfeng Li, et al.
Ejhaem|June 19, 2024
Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: Respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patientsErica Franceschini, Valentina Menozzi, Vera Todisco, et al.
Ejhaem|June 19, 2024
Lymph node tuberculosis-associated paradoxical immune reconstitution inflammatory syndrome in a non-HIV patient: Case report and review of literatureAndré Rodrigues Guimarães, Juliana Bastos, Lurdes Santos, et al.
Ejhaem|April 18, 2024
Graft-versus-host disease after autologous stem cell transplantation in a recipient who underwent allogeneic stem cell transplantation 20 years earlierOsamu Imataki, Shunsuke Yoshida, Tomoya Ishida, et al.
Ejhaem|August 21, 2023
Presence but not number of secondary type mutations influences outcome in de novo AML without MDS-associated or recurring cytogenetic abnormalitiesOlga K Weinberg, Miguel D Cantu, Jeffrey Gagan, et al.
Pageof 97